Grants for tribes in New Mexico
Federal agencies awarded $1.2 billion in 2,110 grants to tribes in New Mexico from fiscal 2021 to 2025. The largest source was Highway Planning and Construction. 852 federal grant opportunities are open or forecast now for tribes.
- New Mexico ranks 7th of the 50 states and DC for federal grants to tribes.
- Grants to tribes made up 2% of all federal grant money to recipients in New Mexico.
- That is 4% of all federal grant money to tribes nationwide.
- Awarded, FY 2021 to 2025$1.2 billion
- Grant awards2,110
- Open now nationwide852
Federal programs that fund tribes in New Mexico
| Program | Awarded to tribes in New Mexico |
|---|---|
| Highway Planning and Construction | $179 million |
| Tribal Broadband Connectivity Program | $164 million |
| Indian Housing Block Grants | $110 million |
| Head Start | $90.9 million |
| Child Care and Development Block Grant | $57.1 million |
| Substance Abuse and Mental Health Services Projects of Regional and National Significance | $39.0 million |
| WIC Special Supplemental Nutrition Program for Women, Infants, and Children | $37.0 million |
| Special Diabetes Program for Indians Diabetes Prevention and Treatment Projects | $27.4 million |
| Grid Infrastructure Deployment and Resilience | $24.5 million |
| Education Stabilization Fund | $24.5 million |
Open federal grants tribes can apply for
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Open Closes November 2, 2026 (2 days left) - Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Open Closes November 2, 2026 (2 days left) - National Indian Health Outreach and Education
Open Closes November 2, 2026 (2 days left) - BJA FY 2026 Upholding the Rule of Law and Preventing Wrongful Convictions Program
Open Closes November 2, 2026 (2 days left) - OJJDP FY 2026 Second Chance Act Youth Reentry Program
Open Closes November 2, 2026 (2 days left) - Topology
Open Closes November 3, 2026 (3 days left) - Geometric Analysis
Open Closes November 3, 2026 (3 days left) - BJA FY 2026 Edward Byrne Memorial Justice Assistance Grant (JAG) Program—Local Formula
Open Closes November 3, 2026 (3 days left) - DoW Reconstructive Transplant, Concept Award
Open Closes November 4, 2026 (4 days left) - DoW Bone Marrow Failure, Idea Development Award
Open Closes November 4, 2026 (4 days left) - DoW Bone Marrow Failure, Investigator-Initiated Research Award
Open Closes November 4, 2026 (4 days left) - DoW Bone Marrow Failure, Resource Development Award
Open Closes November 4, 2026 (4 days left) - DoW Reconstructive Transplant, Investigator-Initiated Research Award
Open Closes November 4, 2026 (4 days left) - Exploring and Enhancing Outdoor and Heritage Tourism in the Chesapeake Bay Watershed
Open Closes November 4, 2026 (4 days left) - Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
Open Closes November 5, 2026 (5 days left) - Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
Open Closes November 5, 2026 (5 days left) - US Travelers Health Research, Surveillance, Communication, and Outreach Network
Open Closes November 5, 2026 (5 days left) - Request for Information - Gauging Investor Interest in the Development and Commercialization of Subsurface Energy Technologies
Open Closes November 5, 2026 (5 days left) - Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
Open Closes November 6, 2026 (6 days left) - DoW Parkinson’s, Early Investigator Research Award
Open Closes November 6, 2026 (6 days left) - DoW Parkinson’s, Investigator-Initiated Research Award
Open Closes November 6, 2026 (6 days left) - Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
Open Closes November 10, 2026 (10 days left) - Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
Open Closes November 10, 2026 (10 days left) - Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Open Closes November 10, 2026 (10 days left) - Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Open Closes November 10, 2026 (10 days left)
See all 852 open grants for tribes